152 related articles for article (PubMed ID: 26479549)
1. Irisin in the Glucose Continuum.
Assyov Y; Gateva A; Tsakova A; Kamenov Z
Exp Clin Endocrinol Diabetes; 2016 Jan; 124(1):22-7. PubMed ID: 26479549
[TBL] [Abstract][Full Text] [Related]
2. Irisin levels in the progression of diabetes in sedentary women.
Duran ID; Gülçelik NE; Ünal M; Topçuoğlu C; Sezer S; Tuna MM; Berker D; Güler S
Clin Biochem; 2015 Dec; 48(18):1268-72. PubMed ID: 26234637
[TBL] [Abstract][Full Text] [Related]
3. Myostatin and carbohydrate disturbances.
Assyov YS; Velikova TV; Kamenov ZA
Endocr Res; 2017 May; 42(2):102-109. PubMed ID: 27356124
[TBL] [Abstract][Full Text] [Related]
4. Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations.
Ebert T; Kralisch S; Wurst U; Scholz M; Stumvoll M; Kovacs P; Fasshauer M; Tönjes A
Int J Obes (Lond); 2016 Feb; 40(2):260-5. PubMed ID: 26285604
[TBL] [Abstract][Full Text] [Related]
5. Lower circulating irisin is associated with type 2 diabetes mellitus.
Liu JJ; Wong MD; Toy WC; Tan CS; Liu S; Ng XW; Tavintharan S; Sum CF; Lim SC
J Diabetes Complications; 2013; 27(4):365-9. PubMed ID: 23619195
[TBL] [Abstract][Full Text] [Related]
6. Association between irisin and homocysteine in euglycemic and diabetic subjects.
Alis R; Sanchis-Gomar F; Pareja-Galeano H; Hernández-Mijares A; Romagnoli M; Víctor VM; Rocha M
Clin Biochem; 2014 Dec; 47(18):333-5. PubMed ID: 25192692
[TBL] [Abstract][Full Text] [Related]
7. Serum irisin levels in new-onset type 2 diabetes.
Choi YK; Kim MK; Bae KH; Seo HA; Jeong JY; Lee WK; Kim JG; Lee IK; Park KG
Diabetes Res Clin Pract; 2013 Apr; 100(1):96-101. PubMed ID: 23369227
[TBL] [Abstract][Full Text] [Related]
8. Serum irisin concentration in women with gestational diabetes.
Kuzmicki M; Telejko B; Lipinska D; Pliszka J; Szamatowicz M; Wilk J; Zbucka-Kretowska M; Laudanski P; Kretowski A; Gorska M; Szamatowicz J
Gynecol Endocrinol; 2014 Sep; 30(9):636-9. PubMed ID: 24850254
[TBL] [Abstract][Full Text] [Related]
9. Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects.
Al-Daghri NM; Alkharfy KM; Rahman S; Amer OE; Vinodson B; Sabico S; Piya MK; Harte AL; McTernan PG; Alokail MS; Chrousos GP
Eur J Clin Invest; 2014 Feb; 44(2):119-24. PubMed ID: 24188288
[TBL] [Abstract][Full Text] [Related]
10. Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes.
Liu J; Hu Y; Zhang H; Xu Y; Wang G
J Diabetes Complications; 2016; 30(8):1555-1559. PubMed ID: 27503404
[TBL] [Abstract][Full Text] [Related]
11. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of the myokine irisin in relation to metabolic and renal function.
Ebert T; Focke D; Petroff D; Wurst U; Richter J; Bachmann A; Lössner U; Kralisch S; Kratzsch J; Beige J; Bast I; Anders M; Blüher M; Stumvoll M; Fasshauer M
Eur J Endocrinol; 2014 Apr; 170(4):501-6. PubMed ID: 24399249
[TBL] [Abstract][Full Text] [Related]
13. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy.
Xiang L; Xiang G; Yue L; Zhang J; Zhao L
Atherosclerosis; 2014 Aug; 235(2):328-33. PubMed ID: 24911636
[TBL] [Abstract][Full Text] [Related]
14. Irisin levels in relation to metabolic and liver functions in Egyptian patients with metabolic syndrome.
Rizk FH; Elshweikh SA; Abd El-Naby AY
Can J Physiol Pharmacol; 2016 Apr; 94(4):359-62. PubMed ID: 26695389
[TBL] [Abstract][Full Text] [Related]
15. Habitual physical activity is associated with circulating irisin in healthy controls but not in subjects with diabetes mellitus type 2.
Al-Daghri NM; Alokail MS; Rahman S; Amer OE; Al-Attas OS; Alfawaz H; Tripathi G; Sabico S; Chrousos GP; McTernan PG; Piya MK
Eur J Clin Invest; 2015 Aug; 45(8):775-81. PubMed ID: 26011590
[TBL] [Abstract][Full Text] [Related]
16. Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
García-Fontana B; Reyes-García R; Morales-Santana S; Ávila-Rubio V; Muñoz-Garach A; Rozas-Moreno P; Muñoz-Torres M
Endocrine; 2016 Apr; 52(1):54-62. PubMed ID: 26438394
[TBL] [Abstract][Full Text] [Related]
17. Circulating irisin levels are positively associated with metabolic risk factors in sedentary subjects.
Moreno M; Moreno-Navarrete JM; Serrano M; Ortega F; Delgado E; Sanchez-Ragnarsson C; Valdés S; Botas P; Ricart W; Fernández-Real JM
PLoS One; 2015; 10(4):e0124100. PubMed ID: 25897751
[TBL] [Abstract][Full Text] [Related]
18. Irisin and Testosterone in Men with Metabolic Syndrome.
Kamenov Z; Assyov Y; Angelova P; Gateva A; Tsakova A
Horm Metab Res; 2017 Oct; 49(10):755-759. PubMed ID: 28759938
[TBL] [Abstract][Full Text] [Related]
19. Irisin and its relation to insulin resistance and puberty in obese children: a longitudinal analysis.
Reinehr T; Elfers C; Lass N; Roth CL
J Clin Endocrinol Metab; 2015 May; 100(5):2123-30. PubMed ID: 25781361
[TBL] [Abstract][Full Text] [Related]
20. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study.
Sahin-Efe A; Upadhyay J; Ko BJ; Dincer F; Park KH; Migdal A; Vokonas P; Mantzoros C
Metabolism; 2018 Feb; 79():24-32. PubMed ID: 29108900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
